The effectiveness of nirmatrelvir-ritonavir and molnupiravir for the treatment of COVID-19 among US veterans

Corporate businessmen working on tablet at office

Researchers evaluated the effectiveness of SARS-CoV-2 antivirals, nirmatrelvir-ritonavir, and molnupiravir among Veterans in the United States of America.

Study uncovers factors linked to optimal aging

Previous article

How Medicare Advantage plans dodged auditors and overcharged taxpayers by millions

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News